Evidence map›Paper›PMID 41028258›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Analysis of the Functional Impact of Glycosylation on Immune Checkpoint Proteins.

Maite Emaldi, Esther Rey-Iborra, Paula Alamillo-Maeso, Rafael Pulido, Caroline E Nunes-Xavier

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maite EmaldiBiobizkaia Health Research Institute, Barakaldo, Spain.
Esther Rey-IborraBiobizkaia Health Research Institute, Barakaldo, Spain.
Paula Alamillo-MaesoBiobizkaia Health Research Institute, Barakaldo, Spain.
Rafael PulidoBiobizkaia Health Research Institute, Barakaldo, Spain.
Caroline E Nunes-XavierBiobizkaia Health Research Institute, Barakaldo, Spain. CarolineElisabeth.Nunes-Xavier@bio-bizkaia.eus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B7 immune checkpoint proteins play an important role in modulating antitumor immune response. These proteins interact with co-inhibitory or co-stimulatory receptors on immune and tumor cells, and their expression associates with cancer progression and poor prognosis. B7 proteins are highly glycosylated, as part of their posttranslational modification process. This process consists of the covalent addition of glycans to proteins, which directly affects protein expression, stability, localization, and interaction with partners. Protein glycosylation of immune checkpoint proteins has also been linked to therapy response and immune evasion. Here, we describe experimental methodologies to study the molecular and clinical impact of glycosylation on the B7 family of glycoproteins. We summarize experimental protocols and technical notes to assess the N-glycosylation of B7 proteins, and to study the functional effect of glycosylation on the expression and localization of B7 proteins.

Indexed as

B7 AntigensImmune Checkpoint ProteinsGlycosylationHumansNeoplasmsProtein Processing, Post-TranslationalB7 AntigensImmune Checkpoint ProteinsB7 immune checkpoint proteinsDeglycosylationGlycanaseN-glycosylationProtein expression and stabilityProtein localization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.